UCSF has revealed how blood vessel cells develop in the prenatal human brain, paving the way to fully understand the role of these cells in healthy brain development and disease.
UC Davis Health has reached an institutional milestone, surpassing 5,000 kidney transplants performed since its first 37 years ago. The Transplant Center currently ranks in the top 10 in the nation in terms of the number of kidney transplants.
The UC Davis MIND Institute’s Distinguished Lecturer Series returns in October with in-person presentations for the first time in more than two years. The lineup of speakers includes scientists doing impactful research on autistic youth, brain development, ADHD in girls and women and more.
UC Davis Health researchers received a $1.05 million grant from the Centers for Disease Control and Prevention to identify risk and protective factors linked to the combined use of opioids and benzodiazepines, a group of drugs used to treat anxiety and insomnia.
UCSF Health’s Heart and Vascular Center is welcoming Sammy Elmariah, MD, MPH, FACC, FAHA, FSCAI, as chief of its division of Interventional Cardiology and medical director of the division’s cardiac catheterization lab. Elmariah is a recognized expert in structural heart disease interventions and catheter-based valve therapies.
Scientists have designed compounds that hit the same key receptor that LSD activates without causing hallucinations. A single dose produced powerful antidepressant and antianxiety effects in mice that lasted up to two weeks.
The new UCSF Rosenman Institute BUILD™ Heart Health program is designed as an 11-month cycle of fully funded fellowships aimed at training the next generation of health technology entrepreneurs.
